Log in or Sign up for Free to view tailored content for your specialty!
Cardiology Headline News
Topol: AI-fueled ‘keyboard liberation’ will improve the medical encounter
BOSTON — “We should be embracing [AI] and trying to make this a priority to get this right, because I don’t know any alternative to get us out of this frustration right now outside of this technology,” Eric Topol, MD, said.
Survival rates, outcomes favorable for those given ECMO with neurosurgical intervention
DENVER —Extracorporeal membrane oxygenation therapy led to favorable survival and neurologic outcomes for patients who required neurosurgical intervention, according to a poster at the American Academy of Neurology annual meeting.
Q&A: Obesity Medicine 2024 is ‘a pinnacle moment,’ featuring latest updates in treatment
Hundreds of clinicians will gather in Denver next week to discuss the latest treatment strategies and evidence-based approaches to obesity management.
Log in or Sign up for Free to view tailored content for your specialty!
Gene therapy to treat congestive heart failure gains FDA fast track designation
Bayer AG and its subsidiary Asklepios BioPharmaceutical announced the FDA granted fast track designation for its investigational gene therapy for the treatment of congestive heart failure.
Heart failure a more common complication than stroke in people with atrial fibrillation
In a large Danish cohort, heart failure was a more significant CV complication than stroke after diagnosis of atrial fibrillation, which became more common over 20 years.
Q&A: First responders need to be trained in how women present with heart attack
Too often, heart attack signals are missed or misdiagnosed in women, not just by patients and providers, but by first responders as well.
Am I allowed to be quiet? Looking through the lens of an introvert in medicine
Ever since my third-year clinical rotations in medical school, I can usually predict what will be written about me in my evaluations before seeing them.
Tirzepatide improves sleep apnea symptoms for adults with OSA plus obesity
Adults with moderate to severe obstructive sleep apnea and obesity had reductions in sleep apnea severity at 1 year with 10 mg or 15 mg of tirzepatide, according to topline results from two phase 3 trials.
E-cigarette use could raise heart failure risk up to 19%
ATLANTA — Individuals with a history of e-cigarette use may have increased risk for incident heart failure, regardless of concomitant cigarette, cigar, hookah or smokeless cigarette use, a speaker reported.
Arrhythmias tied to poorer survival in adults with congenital heart disease
Arrhythmia disorders in patients with adult congenital heart disease may significantly contribute to hospitalization and mortality risk, according to data published in the Journal of the American Heart Association.
-
Headline News
Tirzepatide improves sleep apnea symptoms for adults with OSA plus obesity
April 17, 20242 min read -
Headline News
FDA approves Selarsdi as Stelara biosimilar for psoriasis, psoriatic arthritis
April 17, 20241 min read -
Headline News
LVAD obstruction linked to 14 deaths; FDA designates recall as class I
April 15, 20241 min read
-
Headline News
Tirzepatide improves sleep apnea symptoms for adults with OSA plus obesity
April 17, 20242 min read -
Headline News
FDA approves Selarsdi as Stelara biosimilar for psoriasis, psoriatic arthritis
April 17, 20241 min read -
Headline News
LVAD obstruction linked to 14 deaths; FDA designates recall as class I
April 15, 20241 min read